We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+7.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.5B
AUM Growth
+$857M
(+24%)
Cap. Flow
+$670M
Cap. Flow
% of AUM
14.88%
Top 10 Holdings %
Top 10 Hldgs %
17.64%
Holding
512
New
198
Increased
109
Reduced
79
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMSG
Amsurg Corp
AMSG
|
+$73.5M |
| 2 |
RCAP
RCS CAPITAL CORPORATION CLASS A COM
RCAP
|
+$39.5M |
| 3 |
VISN
Vistance Networks Inc
VISN
|
+$37.4M |
| 4 |
Mohawk Industries
MHK
|
+$36.3M |
| 5 |
Aramark
ARMK
|
+$31.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PF
Pinnacle Foods, Inc.
PF
|
+$34.3M |
| 2 |
Pfizer
PFE
|
+$32.3M |
| 3 |
Rockwell Automation
ROK
|
+$31.2M |
| 4 |
FRX
FOREST LABORATORIES INC
FRX
|
+$31.1M |
| 5 |
Netflix
NFLX
|
+$28.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.99% |
| 2 | Industrials | 12.65% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 9.16% |
| 5 | Energy | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Blackstone
BX
$110B
| – | – |
-127,947
| Closed | -$4.17M |
|
402
Caterpillar
CAT
$388B
| – | – |
-228,413
| Closed | -$22.7M |
|
403
Chegg
CHGG
$100M
| – | – |
-383,312
| Closed | -$2.68M |
|
404
CALL
Compass Minerals
CMP
$1.16B
| – | – |
-114,800
| Closed | -$9.47M |
|
405
CALL
Canadian Natural Resources
CNQ
$95B
| – | – |
-232,505
| Closed | -$4.31M |
|
406
CALL
Capital One
COF
$133B
| – | – |
-161,200
| Closed | -$12.4M |
|
|
407
PUT
Capital One
COF
$133B
| – | – |
-181,300
| Closed | -$14M |
|
408
Charles River Laboratories
CRL
$12.5B
| – | – |
-317,053
| Closed | -$19.1M |
|
409
CALL
Delta Air Lines
DAL
$60.1B
| – | – |
-28,200
| Closed | -$977K |
|
410
Dana Inc
DAN
$3.08B
| – | – |
-561,408
| Closed | -$13.1M |
|
411
CALL
Dollar General
DG
$28B
| – | – |
-22,500
| Closed | -$1.25M |
|
412
HF Sinclair
DINO
$14.6B
| – | – |
-126,050
| Closed | -$6M |
|
413
CALL
Dollar Tree
DLTR
$25.2B
| – | – |
-206,300
| Closed | -$10.8M |
|
|
414
Dollar Tree
DLTR
$25.2B
| – | – |
-219,150
| Closed | -$11.4M |
|
|
415
PUT
Dollar Tree
DLTR
$25.2B
| – | – |
-355,600
| Closed | -$18.6M |
|
416
iShares MSCI Emerging Markets ETF
EEM
$29.4B
| – | – |
-22,500
| Closed | -$955K |
|
417
Estee Lauder
EL
$32.1B
| – | – |
-199,307
| Closed | -$13.3M |
|
418
Elevance Health
ELV
$85.6B
| – | – |
-219,353
| Closed | -$21.8M |
|
419
General Mills
GIS
$19.5B
| – | – |
-240,755
| Closed | -$12.5M |
|
420
General Motors
GM
$76.9B
| – | – |
-70,000
| Closed | -$2.41M |
|
421
CALL
Halliburton
HAL
$26.7B
| – | – |
-67,600
| Closed | -$3.98M |
|
|
HES
422
DELISTED
Hess
HES
| – | – |
-254,107
| Closed | -$21.1M |
|
423
Herc Holdings
HRI
$5.7B
| – | – |
-243,743
| Closed | -$19.5M |
|
424
CALL
H&R Block
HRB
$5.87B
| – | – |
-540,700
| Closed | -$16.3M |
|
425
Hershey
HSY
$36.7B
| – | – |
-32,680
| Closed | -$3.41M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2014 Portfolio in Review
As of Q2 2014, Alyeska Investment Group held 512 positions worth $4.5B, up 24% from $3.64B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Alyeska Investment Group deployed $670M of net new capital in Q2 2014, opening 198 new positions and adding to 109 existing holdings. Its largest new stake was Amsurg Corp: 1,600,000 shares worth $72.9M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Pinnacle Foods, Inc., an estimated $34.3M trimmed.
- Alyeska Investment Group's largest Q2 2014 buy was Amsurg Corp: 1,600,000 shares worth $72.9M.
- Alyeska Investment Group added most to Capital One in Q2 2014, an estimated $18.5M increase.
- Alyeska Investment Group's biggest Q2 2014 reduction was Pinnacle Foods, Inc., cutting an estimated $34.3M.
- Alyeska Investment Group fully exited Pfizer in Q2 2014, selling an estimated $32.3M.
- Alyeska Investment Group's ten largest holdings make up 18% of its $4.5B portfolio in Q2 2014.
- Alyeska Investment Group opened 198 new positions and closed 118 in Q2 2014.
- Alyeska Investment Group's portfolio value rose 24% quarter-over-quarter to $4.5B.
Based on Alyeska Investment Group's 13F filing for Q2 2014, filed 14 Aug 2014.